Previous 10 | Next 10 |
Extends certain exclusive U.S. rights to Ampligen for cancer and ME/CFS through 2039 Management discusses patent issuance and what this means in a brief video: here OCALA, Fla., Nov. 27, 2023 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM...
No severe adverse events reported to date Topline data expected as early as Q1 2024 OCALA, Fla., Nov. 21, 2023 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced the last subject has completed...
2023-11-15 13:39:04 ET AIM ImmunoTech Inc. (AIM) Q3 2023 Earnings Call Transcript November 15, 2023 08:00 AM ET Company Participants Thomas Equels - Executive Vice Chairman, Chief Executive Officer and President Christopher McAleer - Scientific Officer Conferen...
2023-11-15 07:37:48 ET More on AIM ImmunoTech Seeking Alpha’s Quant Rating on AIM ImmunoTech Historical earnings data for AIM ImmunoTech Financial information for AIM ImmunoTech For further details see: AIM ImmunoTech GAAP EPS of -$0.16 misses by $...
– Highlights continued execution across Ampligen ® clinical development programs – Company is well positioned to achieve multiple value-driving milestones during remainder of 2023 and 2024 – Will host conference call and webcast today, November 15 ...
2023-11-14 10:52:25 ET Major earnings expected before the bell on Wednesday include: JD.com ( JD ) Tencent Holdings ( OTCPK:TCEHY ) Target ( TGT ) XPeng ( XPEV ) ZIM Integrated Shipping Services ( ZIM ) For further details see: Notable ear...
OCALA, Fla., Nov. 14, 2023 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced the publication of results from the Phase 1 study at Roswell Park Comprehensive Cancer Center in patients with metastatic triple...
ABU DHABI, United Arab Emirates, Nov. 13, 2023 (GLOBE NEWSWIRE) -- The Global Media Congress is scheduled to take place in Abu Dhabi, UAE, from November 14 to 16, 2023, following its successful 2022 edition. This year, AI-Media , will play a central role as the live caption and ...
2023-11-11 01:30:00 ET Summary Long Cast Advisers, LLC, is an independent-registered investment adviser investing on behalf of individuals, family offices and endowments. It is concentrated on long-term investing, focused on small-cap companies. Long Cast Advisors achieved cumulat...
OCALA, Fla., Nov. 09, 2023 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”), announced today that management will host a conference call and webcast to discuss the Company’s Q3 2023 operational and financial r...
News, Short Squeeze, Breakout and More Instantly...
AIM ImmunoTech Inc. Company Name:
AIM Stock Symbol:
NYSE Market:
OCALA, Fla., May 31, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that it has entered into a securities purchase agreement with a single institutional investor to purchase 5,640,958 shares of common stoc...
SINGAPORE, May 22, 2024 (GLOBE NEWSWIRE) -- AI-Media, world leaders in AI-powered captioning solutions, announces its participation in the Broadcast Asia Expo 2024, held from May 29th to 31st at the Singapore Expo. At Booth #5L3-3, AI-Media will unveil its latest advancements in broadcast caption...
OCALA, Fla., May 20, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE:AIM) ("AIM" or the "Company") today announced that AIM Chief Executive ...